Christopher J Twelves

Christopher J Twelves

UNVERIFIED PROFILE

Are you Christopher J Twelves?   Register this Author

Register author
Christopher J Twelves

Christopher J Twelves

Publications by authors named "Christopher J Twelves"

Are you Christopher J Twelves?   Register this Author

14Publications

455Reads

48Profile Views

Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.

J Clin Oncol 2015 May 20;33(15):1680-7. Epub 2015 Apr 20.

John M.S. Bartlett, Ontario Institute for Cancer Research; Frances P. O'Malley, St Michael's Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto; John M.S. Bartlett, Frances P. O'Malley, and Lois E. Shepherd, National Cancer Institute of Canada Clinical Trials Group; Lois E. Shepherd, Queen's University, Kingston, Canada; John M.S. Bartlett, Alison F. Munro, and David A. Cameron, University of Edinburgh, Edinburgh; Christopher C. McConkey, Janet A. Dunn, and Christopher J. Poole, University of Warwick, Coventry; Helena M. Earl and Carlos Caldas, University of Cambridge, Cambridge; Christopher J. Twelves, St James's University Hospital, Leeds; Daniel W. Rea, University of Birmingham, Birmingham, United Kingdom; Christine Desmedt and Denis P. Larsimont, Université Libre de Bruxelles, Brussels, Belgium; Fatima Cardoso, Champalimaud Cancer Centre, Lisbon, Portugal; Maj-Britt Jensen and Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; and Angelo Di Leo, Hospital of Prato, Prato, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.7869DOI Listing
May 2015

A qualitative investigation of the motivations, experiences and views of female sunbed users under the age of 18 in England.

J Public Health (Oxf) 2014 Mar 30;36(1):56-64. Epub 2013 Jan 30.

NHS North Central London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/pubmed/fds107DOI Listing
March 2014

Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?

Clin Cancer Res 2011 Jul 16;17(13):4214-24. Epub 2011 May 16.

Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2848DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131422PMC
July 2011

Targeting the protein kinase C family: are we there yet?

Nat Rev Cancer 2007 07;7(7):554-62

University of Toronto, Department of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc2168DOI Listing
July 2007

Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).

Expert Rev Anticancer Ther 2002 Feb;2(1):13-22

Cancer Research UK, Department of Medical Oncology, Alexander Stone Building, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2.1.13DOI Listing
February 2002